Endovascular treatment of intracranial aneurysms (IAs) has evolved considerably over the
past decades. The technological advances have been driven by the experience that coils fail …

Unruptured intracranial aneurysms often have a relatively benign clinical course. Frequently,
they are found incidentally during workup for an underlying, possibly related or unrelated …

Background Preliminary clinical studies on the safety and efficacy of the pipeline
embolization device (PED) for the treatment of small/medium aneurysms have demonstrated …

Background Evaluating a new endovascular treatment for intracranial aneurysms must not
only demonstrate short-term safety and efficacy, but also evaluate longer-term outcomes (eg …

Background The pipeline embolization device (PED; Medtronic) has presented as a safe
and efficacious treatment for small-and medium-sized intracranial aneurysms …

OBJECTIVE Flow diversion requires neointimal stent overgrowth to deliver aneurysm
occlusion. The existing literature on aneurysm occlusion is limited by heterogeneous follow …

BACKGROUND AND PURPOSE: Flow diverters with antithrombotic coatings are
increasingly used to improve the safety of flow diverter treatments of intracranial aneurysms …

Flow diverters (FDs) have changed the management of brain aneurysms; not only for
complex aneurysms (giant, fusiform and blister) refractory to conventional therapies, but also …

The cost of clinical trials is ever-increasing. In-silico trials rely on virtual populations and
interventions simulated using patient-specific models and may offer a solution to lower these …

BACKGROUND Prospective studies have established the safety and efficacy of the Pipeline
TM Embolization Device (PED; Medtronic) for treatment of intracranial aneurysms (IA) …